(Q87722866)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365412%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

Tightening our understanding of intensive glycaemic control (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365412%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365412%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

William G Herrington

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365412%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

30 March 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365412%20AND%20SRC:MED&resulttype=core&format=json

The Lancet: Diabetes & Endocrinology

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365412%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365412%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365412%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

405-407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365412%20AND%20SRC:MED&resulttype=core&format=json

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

14 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930095-5

7 January 2021

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930095-5

7 January 2021

Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930095-5

7 January 2021

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930095-5

7 January 2021

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930095-5

7 January 2021

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930095-5

7 January 2021

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930095-5

7 January 2021

10.1016/S2213-8587(17)30095-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28365412%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference